As of 2025-07-11, the Relative Valuation of Regenxbio Inc (RGNX) is (94.47) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.06 USD, the upside of Regenxbio Inc based on Relative Valuation is -1142.7%.
The range of the Relative Valuation is (79.66) - (95.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.7x - 30.3x | 27.2x |
| Forward P/E multiples | 25.3x - 42.7x | 32.9x |
| Fair Price | (79.66) - (95.19) | (94.47) |
| Upside | -979.3% - -1150.7% | -1142.7% |
| Date | P/E |
| 2025-07-03 | -2.78 |
| 2025-07-02 | -2.74 |
| 2025-07-01 | -2.62 |
| 2025-06-30 | -2.61 |
| 2025-06-27 | -2.67 |
| 2025-06-26 | -2.78 |
| 2025-06-25 | -2.72 |
| 2025-06-24 | -2.72 |
| 2025-06-23 | -2.50 |
| 2025-06-20 | -2.68 |
| 2025-06-18 | -2.73 |
| 2025-06-17 | -2.75 |
| 2025-06-16 | -2.91 |
| 2025-06-13 | -2.95 |
| 2025-06-12 | -3.24 |
| 2025-06-11 | -3.24 |
| 2025-06-10 | -3.12 |
| 2025-06-09 | -3.03 |
| 2025-06-06 | -3.06 |
| 2025-06-05 | -2.66 |
| 2025-06-04 | -3.21 |
| 2025-06-03 | -3.22 |
| 2025-06-02 | -3.29 |
| 2025-05-30 | -2.82 |
| 2025-05-29 | -2.85 |
| 2025-05-28 | -2.72 |
| 2025-05-27 | -2.89 |
| 2025-05-23 | -3.09 |
| 2025-05-22 | -3.14 |
| 2025-05-21 | -3.07 |
| 2025-05-20 | -3.18 |
| 2025-05-19 | -3.11 |
| 2025-05-16 | -2.83 |
| 2025-05-15 | -2.75 |
| 2025-05-14 | -2.65 |
| 2025-05-13 | -2.60 |
| 2025-05-12 | -2.54 |
| 2025-05-09 | -2.39 |
| 2025-05-08 | -2.27 |
| 2025-05-07 | -2.30 |
| 2025-05-06 | -2.52 |
| 2025-05-05 | -3.10 |
| 2025-05-02 | -3.31 |
| 2025-05-01 | -3.13 |
| 2025-04-30 | -3.06 |
| 2025-04-29 | -2.99 |
| 2025-04-28 | -2.90 |
| 2025-04-25 | -2.91 |
| 2025-04-24 | -2.93 |
| 2025-04-23 | -2.82 |